| Ted Edward Zegarra, MD | |
|
1739 E Beverly Ave, Suite 201, Kingman, AZ 86409-3593 | |
| (928) 692-3456 | |
| (928) 692-7071 |
| Full Name | Ted Edward Zegarra |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 45 Years |
| Location | 1739 E Beverly Ave, Kingman, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063492676 | NPI | - | NPPES |
| 871203 | Medicaid | AZ | |
| 29946 | Other | AZ | MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 29946 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kingman Regional Medical Center | Kingman, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bhsm Rehabilitation Llc | 2062773138 | 1258 |
| Kingman Healthcare Inc | 6901791367 | 181 |
News Archive
PhotoMedex, Inc. announced today that John Koo, MD will be the principal investigator in a clinical study assessing the efficacy of the XTRAC Velocity® excimer laser in the treatment of generalized psoriasis when used in combination with Clobex® spray. Dr. Koo is Professor and Vice Chairman in the Department of Dermatology at the University of California San Francisco Medical Center. Spearheading the study will be Dr. Koo's colleague, Tina Bhutani, MD.
The Lupus Research Institute today announced the award of 12 new research grants, building on its decade-long commitment to drive innovation and discover novel approaches to understand and treat one of the world's most confounding and elusive diseases - lupus.
The Baylor University Medical Center in Dallas has taken delivery of the Naviscan PEM scanner at its Darlene G. Cass Women's Imaging Center. Baylor will utilize PEM (Positron Emission Mammography) to complement their existing anatomical tools by providing a critical three-dimensional metabolic perspective of breast cancer. The metabolic view allows physicians to make the optimal cancer care decisions by providing an unprecedented ability to distinguish between benign and malignant lesions in what researchers call "specificity".
A major study published in the New England Journal of Medicine is providing the best evidence to date that a 21-gene test done on the tumor can identify breast cancer patients who can safely avoid chemotherapy.
The National Science Foundation has awarded $550,000 to fund a collaborative new research project to develop a noninvasive, computational modeling technology for assessing the likelihood of a heart attack in patients with high levels of plaque buildup in their arteries - the primary cause of heart attack in the U.S. today.
› Verified 1 days ago
| Entity Name | Kingman Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265423917 PECOS PAC ID: 6901791367 Enrollment ID: O20040216001173 |
News Archive
PhotoMedex, Inc. announced today that John Koo, MD will be the principal investigator in a clinical study assessing the efficacy of the XTRAC Velocity® excimer laser in the treatment of generalized psoriasis when used in combination with Clobex® spray. Dr. Koo is Professor and Vice Chairman in the Department of Dermatology at the University of California San Francisco Medical Center. Spearheading the study will be Dr. Koo's colleague, Tina Bhutani, MD.
The Lupus Research Institute today announced the award of 12 new research grants, building on its decade-long commitment to drive innovation and discover novel approaches to understand and treat one of the world's most confounding and elusive diseases - lupus.
The Baylor University Medical Center in Dallas has taken delivery of the Naviscan PEM scanner at its Darlene G. Cass Women's Imaging Center. Baylor will utilize PEM (Positron Emission Mammography) to complement their existing anatomical tools by providing a critical three-dimensional metabolic perspective of breast cancer. The metabolic view allows physicians to make the optimal cancer care decisions by providing an unprecedented ability to distinguish between benign and malignant lesions in what researchers call "specificity".
A major study published in the New England Journal of Medicine is providing the best evidence to date that a 21-gene test done on the tumor can identify breast cancer patients who can safely avoid chemotherapy.
The National Science Foundation has awarded $550,000 to fund a collaborative new research project to develop a noninvasive, computational modeling technology for assessing the likelihood of a heart attack in patients with high levels of plaque buildup in their arteries - the primary cause of heart attack in the U.S. today.
› Verified 1 days ago
| Entity Name | The Lingenfelter Center, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265432777 PECOS PAC ID: 2860301553 Enrollment ID: O20191125001553 |
News Archive
PhotoMedex, Inc. announced today that John Koo, MD will be the principal investigator in a clinical study assessing the efficacy of the XTRAC Velocity® excimer laser in the treatment of generalized psoriasis when used in combination with Clobex® spray. Dr. Koo is Professor and Vice Chairman in the Department of Dermatology at the University of California San Francisco Medical Center. Spearheading the study will be Dr. Koo's colleague, Tina Bhutani, MD.
The Lupus Research Institute today announced the award of 12 new research grants, building on its decade-long commitment to drive innovation and discover novel approaches to understand and treat one of the world's most confounding and elusive diseases - lupus.
The Baylor University Medical Center in Dallas has taken delivery of the Naviscan PEM scanner at its Darlene G. Cass Women's Imaging Center. Baylor will utilize PEM (Positron Emission Mammography) to complement their existing anatomical tools by providing a critical three-dimensional metabolic perspective of breast cancer. The metabolic view allows physicians to make the optimal cancer care decisions by providing an unprecedented ability to distinguish between benign and malignant lesions in what researchers call "specificity".
A major study published in the New England Journal of Medicine is providing the best evidence to date that a 21-gene test done on the tumor can identify breast cancer patients who can safely avoid chemotherapy.
The National Science Foundation has awarded $550,000 to fund a collaborative new research project to develop a noninvasive, computational modeling technology for assessing the likelihood of a heart attack in patients with high levels of plaque buildup in their arteries - the primary cause of heart attack in the U.S. today.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ted Edward Zegarra, MD 1739 E Beverly Ave, Suite 201, Kingman, AZ 86409-3593 Ph: (928) 692-3456 | Ted Edward Zegarra, MD 1739 E Beverly Ave, Suite 201, Kingman, AZ 86409-3593 Ph: (928) 692-3456 |
News Archive
PhotoMedex, Inc. announced today that John Koo, MD will be the principal investigator in a clinical study assessing the efficacy of the XTRAC Velocity® excimer laser in the treatment of generalized psoriasis when used in combination with Clobex® spray. Dr. Koo is Professor and Vice Chairman in the Department of Dermatology at the University of California San Francisco Medical Center. Spearheading the study will be Dr. Koo's colleague, Tina Bhutani, MD.
The Lupus Research Institute today announced the award of 12 new research grants, building on its decade-long commitment to drive innovation and discover novel approaches to understand and treat one of the world's most confounding and elusive diseases - lupus.
The Baylor University Medical Center in Dallas has taken delivery of the Naviscan PEM scanner at its Darlene G. Cass Women's Imaging Center. Baylor will utilize PEM (Positron Emission Mammography) to complement their existing anatomical tools by providing a critical three-dimensional metabolic perspective of breast cancer. The metabolic view allows physicians to make the optimal cancer care decisions by providing an unprecedented ability to distinguish between benign and malignant lesions in what researchers call "specificity".
A major study published in the New England Journal of Medicine is providing the best evidence to date that a 21-gene test done on the tumor can identify breast cancer patients who can safely avoid chemotherapy.
The National Science Foundation has awarded $550,000 to fund a collaborative new research project to develop a noninvasive, computational modeling technology for assessing the likelihood of a heart attack in patients with high levels of plaque buildup in their arteries - the primary cause of heart attack in the U.S. today.
› Verified 1 days ago
Ashley Marie Eyer, Family Medicine Medicare: Medicare Enrolled Practice Location: 2668 Hualapai Mountain Rd, Kingman, AZ 86401 Phone: 928-718-7300 | |
Matthew Bell, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3269 N Stockton Hill Rd, Kingman, AZ 86409 Phone: 928-681-8701 | |
Dr. Kenneth Douglas Jackson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1739 E Beverly Ave, Suite 201, Kingman, AZ 86401 Phone: 928-692-3456 Fax: 928-692-7071 | |
Karleen Carol Adams, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3269 N Stockton Hill Rd, Kingman, AZ 86409 Phone: 928-263-4722 Fax: 928-263-4794 | |
Tadesse Kebede Debele, MD, MS Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2202 N Stockton Hill Rd Ste 101, Kingman, AZ 86401 Phone: 702-877-5199 Fax: 702-431-0265 | |
Kirsten Mortenson, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 3636 N Stockton Hill Rd, Kingman, AZ 86409 Phone: 928-757-4398 Fax: 928-757-7224 |